{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:15:42Z","timestamp":1793420142719,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-024-03599-9","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T02:09:46Z","timestamp":1732586986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of arterial compression hemostasis devices in liver cancer treatment: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Handan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,26]]},"reference":[{"issue":"3","key":"3599_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3599_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"3599_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u201332.","journal-title":"CA Cancer J Clin"},{"issue":"9822","key":"3599_CR4","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","volume":"379","author":"A Forner","year":"2012","unstructured":"Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379(9822):1245\u201355.","journal-title":"Lancet"},{"issue":"12","key":"3599_CR5","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra1001683","volume":"365","author":"HB El-Serag","year":"2011","unstructured":"El-Serag HB. Hepatocellular Carcinoma. N Engl J Med. 2011;365(12):1118\u201327.","journal-title":"N Engl J Med"},{"issue":"5","key":"3599_CR6","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1007\/s10147-015-0796-5","volume":"20","author":"Y Liu","year":"2015","unstructured":"Liu Y, et al. First-line gemcitabine and oxaliplatin (GEMOX) plus sorafenib, followed by sorafenib as maintenance therapy, for patients with advanced hepatocellular carcinoma: a preliminary study. Int J Clin Oncol. 2015;20(5):952\u20139.","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"3599_CR7","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"J Bruix","year":"2011","unstructured":"Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020\u20132.","journal-title":"Hepatology"},{"issue":"9","key":"3599_CR8","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.3748\/wjg.v9.i9.1885","volume":"9","author":"J Qian","year":"2003","unstructured":"Qian J, Feng GS, Vogl T. Combined interventional therapies of hepatocellular carcinoma. World J Gastroenterol. 2003;9(9):1885\u201391.","journal-title":"World J Gastroenterol"},{"key":"3599_CR9","doi-asserted-by":"publisher","first-page":"153303382097066","DOI":"10.1177\/1533033820970665","volume":"19","author":"Y Li","year":"2020","unstructured":"Li Y, et al. Experimental study on evaluation of blood supply level and embolization ratio of Liver Cancer based on I-Flow Software. Technol Cancer Res Treat. 2020;19:1533033820970665.","journal-title":"Technol Cancer Res Treat"},{"key":"3599_CR10","doi-asserted-by":"publisher","first-page":"7173","DOI":"10.2147\/CMAR.S257934","volume":"12","author":"L Guo","year":"2020","unstructured":"Guo L, et al. The Prognostic Value of Inflammation Factors in Hepatocellular Carcinoma Patients with hepatic artery interventional treatments: a retrospective study. Cancer Manag Res. 2020;12:7173\u201388.","journal-title":"Cancer Manag Res"},{"key":"3599_CR11","doi-asserted-by":"crossref","unstructured":"Chintalapati SP, Patel A, Conjeevaram H. Gastric and duodenal ischaemia after transarterial chemoembolisation for hepatocellular carcinoma: an unexpected but significant complication. BMJ Case Rep, 2018. 2018.","DOI":"10.1136\/bcr-2017-223339"},{"issue":"2","key":"3599_CR12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jfma.2019.08.019","volume":"119","author":"PT Lin","year":"2020","unstructured":"Lin PT, et al. The incidence and predictors of post transarterial chemoembolization variceal bleeding in hepatocellular carcinoma patients. J Formos Med Assoc. 2020;119(2):635\u201343.","journal-title":"J Formos Med Assoc"},{"issue":"2","key":"3599_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0741-5214(03)00291-X","volume":"38","author":"BW Starnes","year":"2003","unstructured":"Starnes BW, et al. Percutaneous arterial closure in peripheral vascular disease: a prospective randomized evaluation of the Perclose device. J Vasc Surg. 2003;38(2):263\u201371.","journal-title":"J Vasc Surg"},{"issue":"8","key":"3599_CR14","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s00330-011-2117-3","volume":"21","author":"D Trabattoni","year":"2011","unstructured":"Trabattoni D, et al. A new kaolin-based haemostatic bandage compared with manual compression for bleeding control after percutaneous coronary procedures. Eur Radiol. 2011;21(8):1687\u201391.","journal-title":"Eur Radiol"},{"issue":"8","key":"3599_CR15","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S0002-9149(98)00074-5","volume":"81","author":"JB Pracyk","year":"1998","unstructured":"Pracyk JB, et al. A randomized trial of vascular hemostasis techniques to reduce femoral vascular complications after coronary intervention. Am J Cardiol. 1998;81(8):970\u20136.","journal-title":"Am J Cardiol"},{"issue":"6","key":"3599_CR16","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.jvs.2010.04.079","volume":"52","author":"CF Bechara","year":"2010","unstructured":"Bechara CF, Annambhotla S, Lin PH. Access site management with vascular closure devices for percutaneous transarterial procedures. J Vasc Surg. 2010;52(6):1682\u201396.","journal-title":"J Vasc Surg"},{"issue":"7","key":"3599_CR17","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"issue":"10","key":"3599_CR18","first-page":"pEd000142","volume":"10","author":"M Cumpston","year":"2019","unstructured":"Cumpston M, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10(10):pEd000142.","journal-title":"Cochrane Database Syst Rev"},{"key":"3599_CR19","unstructured":"Higgins JPT, Page SJ. MJ, Revised Cochrane risk of bias tool for randomized trials (RoB 2.0). https:\/\/www.riskofbias.info\/welcome\/rob-2-0-tool\/archive-rob-2-0-2016., 20 October 2016."},{"issue":"01","key":"3599_CR20","first-page":"130","volume":"36","author":"Zhifeng","year":"2014","unstructured":"Zhifeng, Qiu. A comparative study of two methods of compression hemostasis after transcatheter arterial chemoembolization. Fujian J Med. 2014;36(01):130\u20131.","journal-title":"Fujian J Med"},{"issue":"16","key":"3599_CR21","first-page":"152","volume":"2","author":"Liu","year":"2018","unstructured":"Liu, Minmin. Application of two kinds of compression hemostasis methods in postoperative nursing of liver cancer interventional therapy. J Mod Med Health Res Electron J. 2018;2(16):152\u20133.","journal-title":"J Mod Med Health Res Electron J"},{"issue":"23","key":"3599_CR22","first-page":"89","volume":"20","author":"Liu","year":"2016","unstructured":"Liu, Nan, Yujuan Q. Clinical application of the arterial compression hemostat GOLDFINGER in the treatment of hepatocellular carcinoma after transfemoral artery intervention. J Practical Clin Med. 2016;20(23):89\u201390.","journal-title":"J Practical Clin Med"},{"key":"3599_CR23","unstructured":"Zhang Zong-xia, Rui W, Ming-guang Z. Evaluation of the effect of arterial compression hemostat after transcatheter arterial chemoembolization. Chin J Practical Nurs. 2012;28(05):51\u20132."},{"issue":"11","key":"3599_CR24","first-page":"658","volume":"11","author":"Jin","year":"2013","unstructured":"Jin, Tianping. Evaluation of the application effect of arterial compression tourniquet on liver cancer after interventional therapy. Chin Med Guide. 2013;11(11):658\u20139.","journal-title":"Chin Med Guide"},{"issue":"23","key":"3599_CR25","first-page":"252","volume":"16","author":"Li","year":"2018","unstructured":"Li, Juan. Application value of arterial compression hemostat in interventional therapy for patients with advanced liver cancer. J Contemp Med. 2018;16(23):252\u20133.","journal-title":"J Contemp Med"},{"issue":"10","key":"3599_CR26","first-page":"923","volume":"4","author":"J Li","year":"2018","unstructured":"Li J, et al. The application of arterial compression hemostat in patients with primary liver cancer after transcatheter arterial chemoembolization. Evid Based Nurs. 2018;4(10):923\u20135.","journal-title":"Evid Based Nurs"},{"issue":"31","key":"3599_CR27","first-page":"6876","volume":"33","author":"Y Lin Ping","year":"2012","unstructured":"Lin Ping Y, Guozhi, Qin Y. Study on the nursing effect of arterial compression tourniquet hemostasis after interventional therapy for liver cancer. Jilin Med. 2012;33(31):6876\u20137.","journal-title":"Jilin Med"},{"key":"3599_CR28","unstructured":"Shao-mei, Wang. Application of two compression hemostasis methods in postoperative nursing of liver cancer treated with TAE. Contemporary Nurses (The next ten-day Issue), 2013(10): pp. 43\u201344."},{"issue":"29","key":"3599_CR29","first-page":"161","volume":"24","author":"Y Shufang Wang","year":"2017","unstructured":"Shufang Wang Y, He, Pan Y. The application of modified blood pressure cuff compression hemostasis in the treatment of liver cancer after interventional therapy. Chin Contemp Med. 2017;24(29):161\u20133.","journal-title":"Chin Contemp Med"},{"issue":"14","key":"3599_CR30","first-page":"143","volume":"13","author":"R Chengfang","year":"2021","unstructured":"Chengfang R, Bo G. Analysis of the clinical application effect of arterial compression hemostat on liver cancer after interventional therapy. Chin Continuing Med Educ. 2021;13(14):143\u20136.","journal-title":"Chin Continuing Med Educ"},{"issue":"2","key":"3599_CR31","first-page":"663","volume":"24","author":"J Liu Zhao","year":"2014","unstructured":"Liu Zhao J, Wu, Liu Y. Nursing care of the application of arterial compression hemostat after interventional therapy for liver cancer. China Health Nutr (Mid-term Periodical). 2014;24(2):663\u20134.","journal-title":"China Health Nutr (Mid-term Periodical)"},{"issue":"11","key":"3599_CR32","first-page":"59","volume":"30","author":"Ma","year":"2018","unstructured":"Ma, Limin. Hemostatic effect of arterial compression tourniquet on femoral artery puncture in patients with liver cancer after interventional therapy. Chin J Med. 2018;30(11):59\u201361.","journal-title":"Chin J Med"},{"issue":"07","key":"3599_CR33","first-page":"987","volume":"47","author":"Z Huang","year":"2018","unstructured":"Huang Z, Hu W, Jia YG. Clinical application of an arterial compression hemostat in the treatment of hepatocellular carcinoma after interventional therapy. Chongqing Med. 2018;47(07):987\u20138.","journal-title":"Chongqing Med"},{"issue":"22","key":"3599_CR34","first-page":"2072","volume":"26","author":"M Qian","year":"2011","unstructured":"Qian M, Chunmei G. Evaluation of the efficacy of arterial compression tourniquet in the treatment of liver cancer after interventional therapy. J Adv Nurs Educ. 2011;26(22):2072\u20134.","journal-title":"J Adv Nurs Educ"},{"issue":"23","key":"3599_CR35","first-page":"1801","volume":"27","author":"Zhu Ronghua","year":"2010","unstructured":"Zhu Ronghua, Zhang, Guimin. Application of an arterial compression tourniquet in patients undergoing percutaneous coronary intervention through the femoral artery. Chin J Nurs. 2010;27(23):1801\u20132.","journal-title":"Chin J Nurs"},{"issue":"5","key":"3599_CR36","first-page":"72","volume":"29","author":"Zhou","year":"2012","unstructured":"Zhou, Jing, et al. Comparison of the efficacy of different hemostasis methods after liver interventional therapy. Chin J Nurs. 2012;29(5):72\u20133.","journal-title":"Chin J Nurs"},{"issue":"3","key":"3599_CR37","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1001\/jama.291.3.350","volume":"291","author":"M Koreny","year":"2004","unstructured":"Koreny M, et al. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA. 2004;291(3):350\u20137.","journal-title":"JAMA"},{"issue":"13","key":"3599_CR38","first-page":"144","volume":"25","author":"XM Li","year":"2015","unstructured":"Li XM. Clinical nursing of femoral artery compressor in the treatment of femoral arteriovenous fistula after cerebrovascular intervention. Shenzhen J Integr Traditional Chin Western Med. 2015;25(13):144\u20135.","journal-title":"Shenzhen J Integr Traditional Chin Western Med"},{"issue":"35","key":"3599_CR39","first-page":"8633","volume":"11","author":"Wu","year":"2011","unstructured":"Wu, Xueying, et al. Optimal time to relieve the arterial compression hemostat after cerebral angiography. Chin J Misdiagnosis. 2011;11(35):8633\u20134.","journal-title":"Chin J Misdiagnosis"},{"issue":"12","key":"3599_CR40","first-page":"1384","volume":"50","author":"P Xia","year":"2015","unstructured":"Xia P, Chunhui Z, Feng, Jiugeng. The effect of segmental relaxation of the arterial compression hemostat on local complications after transfemoral artery puncture. Jiangxi Med. 2015;50(12):1384\u20135.","journal-title":"Jiangxi Med"},{"issue":"5","key":"3599_CR41","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S0741-5214(03)01020-6","volume":"38","author":"P Negl\u00e9n","year":"2003","unstructured":"Negl\u00e9n P, Thrasher TL, Raju S. Venous outflow obstruction: an underestimated contributor to chronic venous disease. J Vasc Surg. 2003;38(5):879\u201385.","journal-title":"J Vasc Surg"},{"issue":"1","key":"3599_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1148\/radiology.140.1.7244243","volume":"140","author":"VP Chuang","year":"1981","unstructured":"Chuang VP, Wallace S. Hepatic artery embolization in the treatment of hepatic neoplasms. Radiology. 1981;140(1):51\u20138.","journal-title":"Radiology"},{"issue":"3","key":"3599_CR43","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/cncr.10694","volume":"95","author":"E Ando","year":"2002","unstructured":"Ando E, et al. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases. Cancer. 2002;95(3):588\u201395.","journal-title":"Cancer"},{"issue":"4","key":"3599_CR44","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, et al. Sorafenib in Advanced Hepatocellular Carcinoma. N Engl J Med. 2008;359(4):378\u201390.","journal-title":"N Engl J Med"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-024-03599-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-024-03599-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-024-03599-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T16:12:41Z","timestamp":1732637561000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-024-03599-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3599"],"URL":"https:\/\/doi.org\/10.1186\/s12957-024-03599-9","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,26]]},"assertion":[{"value":"7 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"312"}}